NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT1040240149

Registered date:17/12/2024

Organ dysfunction after noncardiac surgery: a prospective observational study

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedDiseases requiring noncardiac major surgery
Date of first enrollment17/12/2024
Target sample size200
Countries of recruitment
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeA composite outcome consisting of acute kidney injury or myocardial injury within 7 days postoperatively
Secondary OutcomeAcute kidney injury (AKI) within 7 days after surgery Acute kidney disease (AKD) and chronic kidney disease (CKD) after surgery Myocardial injury within 7 days and within 30 days after surgery Postoperative cognitive dysfunction Postoperative delirium Resuscitated cardiac arrest within 30 days after surgery Major cardiovascular event within 30 days after surgery Cerebrovascular complications within 30 days after surgery New-onset atrial fibrillation within 30 days after surgery (with symptoms of hypotension, angina, heart failure, or requiring drug therapy or defibrillation) Unexpected postoperative intensive care unit admission Postoperative renal replacement therapy Death from any cause within 7 days, 30 days, 90 days, 1 year after surgery Post-anesthesia care unit (PACU) length of stay Postoperative hospital stay

Key inclusion & exclusion criteria

Age minimum>= 45age old
Age maximumNot applicable
GenderBoth
Include criteria1) Men and women aged 45 or older 2) Patients scheduled to undergo esophagectomy, hepatectomy, biliary surgery, pancreatectomy, abdominal aortic replacement, total cystectomy, or adrenalectomy 3) Patients with an ASA-PS (American Society of Anesthesiologists physical status) of 1 to 4. 4) Patients who have provided written informed consent
Exclude criteria1) Patients who are pregnant or suspected of being pregnant 2) Patients whose will cannot be confirmed 3) Patients on dialysis 4) Patients with a serum creatinine level of >= 4.0 mg/dL at least once within 3 months prior to surgery 5) Patients who have had acute kidney disease, cerebral infarction, cerebral hemorrhage, transient ischemic attack, acute myocardial infarction, angina pectoris, or acute heart failure (including acute exacerbation of chronic heart failure) within 30 days prior to surgery 6) Patients on mechanical ventilation with tracheal intubation prior to surgery 7) Patients receiving continuous intravenous inotropic or vasoconstrictive agents prior to surgery 8) Patients with preoperative shock vital signs 9) Patients with incomplete or erroneous data to be analyzed 10) Patients undergoing emergency surgery 11) Patients who have been the subject of this study in the past 12) Patients who are deemed by the investigators to be unsuitable for the study

Related Information

Contact

Public contact
Name Toshiyuki Nakanishi
Address 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi Aichi Japan 467-8601
Telephone +81-52-853-8281
E-mail nakanishi.anest@gmail.com
Affiliation Nagoya City University Graduate School of Medical Sciences
Scientific contact
Name Toshiyuki Nakanishi
Address 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi Aichi Japan 467-8601
Telephone +81-52-853-8281
E-mail nakanishi.anest@gmail.com
Affiliation Nagoya City University Graduate School of Medical Sciences